Humana Inc. Files 8-K for Regulation FD Disclosure

Ticker: HUM · Form: 8-K · Filed: 2024-09-03T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, disclosure

TL;DR

Humana filed an 8-K for a Reg FD disclosure - watch for updates.

AI Summary

On September 3, 2024, Humana Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, indicating that the company is releasing material non-public information to the public. No specific financial figures or new business developments were detailed in the provided excerpt.

Why It Matters

This filing signals that Humana Inc. is making a public disclosure of information, which could impact investors' understanding of the company's current status or future outlook.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided excerpt does not specify the content of the Regulation FD disclosure, only that the filing is intended to satisfy this requirement.

When was the earliest event reported in this 8-K filing?

The earliest event reported is September 3, 2024.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202.

Under which section of the Securities Exchange Act is this Form 8-K filed?

This Form 8-K is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

What is the Standard Industrial Classification code for Humana Inc.?

The Standard Industrial Classification code for Humana Inc. is 6324, which corresponds to Hospital & Medical Service Plans.

From the Filing

0000049071-24-000042.txt : 20240903 0000049071-24-000042.hdr.sgml : 20240903 20240903072727 ACCESSION NUMBER: 0000049071-24-000042 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240903 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240903 DATE AS OF CHANGE: 20240903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 241271911 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20240903.htm 8-K hum-20240903 0000049071 false 0000049071 2024-09-03 2024-09-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2024 ( September 3, 2024 ) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 001-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street , Louisville , Kentucky 40202 (Address of principal executive offices, including zip code) ( 502 ) 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01 Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at industry conferences and various other meetings between September 3, 2024 and September 30, 2024. During these conferences and meetings, the Company intends to reaffirm its guidance of approximately $12.81 in diluted earnings per common share (“EPS”) or approximately $16.00 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2024 (“FY 2024”). This guidance is consistent with the guidance issued in Humana’s press release dated July 31, 2024. The date and time of presentations to investors are available via the Investo

View on Read The Filing